MRNA CapEx to Revenue

Moderna · CapEx to Revenue

MRNA logo

MRNA CapEx to Revenue

Current (TTM)7.68%
MRNA CapEx/Revenue (30.58% → 7.68%)
High-resolution chart · PNG

MRNA capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
9.8765%
32.854%
10.3242%
2.1192%
1.6013%
8.3954%
52.4074%
78.3057%
28.3741%
30.5768%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.